Open access peer-reviewed chapter

The Evolving Role of Tissue Biospecimens in the Treatment of Cancer

By Wilfrido D. Mojica

Submitted: December 11th 2010Reviewed: May 2nd 2011Published: December 9th 2011

DOI: 10.5772/24740

Downloaded: 1789

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Wilfrido D. Mojica (December 9th 2011). The Evolving Role of Tissue Biospecimens in the Treatment of Cancer, Current Cancer Treatment - Novel Beyond Conventional Approaches, Öner Özdemir, IntechOpen, DOI: 10.5772/24740. Available from:

chapter statistics

1789total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Breast and Ovarian Cancer Treatment: Facing Forward Women's Health Care

By Alice Laschuk Herlinger, Klesia Pirola Madeira, Renata Dalmaschio Daltoé, Ian Victor Silva, Marco César Cunegundes Guimarães and Leticia Batista Azevedo Rangel

Related Book

First chapter

Conventional Cancer Treatment

By Isabella dos Santos Guimarães*, Renata Dalmaschio Daltoé*, Alice Laschuk Herlinger, Klesia Pirola Madeira, Taciane Ladislau, Iuri Cordeiro Valadão, Paulo Cilas Morais Lyra Junior, Sarah Fernandes Teixeira, Gustavo Modesto Amorim, Diandra Zipinotti dos Santos, Karina Rangel Demuth and Leticia Batista Azevedo Rangel

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us